DXA in vivo BMD methodology: An erroneous and misleading research and clinical gauge of bone mineral status, bone fragility, and bone remodelling
- 31 July 2007
- journal article
- review article
- Published by Elsevier BV in Bone
- Vol. 41 (1), 138-154
- https://doi.org/10.1016/j.bone.2007.02.022
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Osteoclast formation and bone resorption are inhibited by megakaryocytesBone, 2006
- Osteoblastic cells regulate the haematopoietic stem cell nicheNature, 2003
- Stemming bone loss by suppressing apoptosisJCI Insight, 1999
- Analytic and quantitative exposition of patient‐specific systematic inaccuracies inherent in planar DXA‐derived in vivo BMD measurementsMedical Physics, 1998
- Expression of growth factor ligand and receptor genes in rat cancellous bone trabeculae and marrowJournal of Molecular Endocrinology, 1996
- Pitfalls in the Measurement of Bone Mineral Density by Dual Energy X-ray AbsorptiometrySpine, 1996
- Body weight versus body fat distribution, adiposity, and frame size as predictors of bone densityJournal of Clinical Endocrinology & Metabolism, 1995
- Accuracy of lateral dual energy X-ray absorptiometry for the determination of bone mineral content in the thoracic and lumbar spine: an in vitro studyThe British Journal of Radiology, 1993
- Perspective how many women have osteoporosis?Journal of Bone and Mineral Research, 1992
- Bone marrow and bone remodelingBone, 1985